Home / Recalls / Revive Rx LLC Dba Revive Rx Pharmacy / D-0771-2023

D-0771-2023 Class II Ongoing

Recalled by Revive Rx LLC Dba Revive Rx Pharmacy — Houston, TX

FDA drug recall D-0771-2023 was initiated by Revive Rx LLC Dba Revive Rx Pharmacy on May 11, 2023 and is designated Class II. Reason for recall: Sub-potent Drug The recall status is ongoing. Affected quantity: 45 Vials.

Recall Details

Product Type: Drugs
Report Date: May 31, 2023
Initiation Date: May 11, 2023
Termination Date: N/A
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 45 Vials

Product Description

Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.

Reason for Recall

Sub-potent Drug

Distribution Pattern

Nationwide in the US

Code Information

Lot: 1643397 BUD: 10/16/2023

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0771-2023
openFDA file date: Oct 6, 2026
Loaded by RegDataLab: Oct 12, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it. FDA may have changed the recall since.